# Example output: funding round Quillfeather Labs is a fictional company. Any resemblance to a real company is coincidence. **Recommended headline:** Quillfeather Labs Raises $12 Million to Predict Hospital Equipment Failures Before They Reach Patients **Alternates:** - Quillfeather Labs Raises $12 Million Series A Led by Harrow Point Ventures - Quillfeather Labs Raises $12 Million to Bring Failure Prediction to Hospital CT and MRI Scanners - Quillfeather Labs Raises $12 Million as 41 Hospitals Use Its Equipment Failure Predictions - Quillfeather Labs Raises $12 Million to Double Engineering Team and Open Second Lab **Subhead:** Harrow Point Ventures led the Series A, which brings Quillfeather Labs' total funding to $15.5 million. ```text FOR IMMEDIATE RELEASE Quillfeather Labs Raises $12 Million to Predict Hospital Equipment Failures Before They Reach Patients Harrow Point Ventures led the Series A, which brings Quillfeather Labs' total funding to $15.5 million. - Quillfeather Labs raised $12 million in Series A funding led by Harrow Point Ventures, with Mill Race Capital and seed investor Tessellate Fund taking part, for a total of $15.5 million raised to date. - Quillfeather Labs' software reads hospital equipment maintenance logs and predicts which infusion pumps and ventilators will fail in the next 30 days, and 41 U.S. hospitals use it, up from nine a year ago. - Quillfeather Labs' analysis of 2025 service records found 31% fewer surprise equipment failures at the nine hospitals that had used its software for a full year, compared with the year before. - Quillfeather Labs will use the funding to double its engineering team, from 14 people to about 30 by the end of 2027, to open a second lab and to extend its predictions to CT and MRI scanners starting in 2027. PITTSBURGH, Oct. 6, 2026 — Quillfeather Labs has raised $12 million in Series A funding led by Harrow Point Ventures to grow its engineering team and extend its failure predictions from infusion pumps and ventilators to CT and MRI scanners. The Pittsburgh company's software tells short-staffed hospital biomedical engineering teams which devices are likely to fail in the next 30 days. When an infusion pump fails mid-shift, nurses scramble for a replacement and patients wait. Hospital biomedical engineering teams are short-staffed and cannot inspect every device on schedule, so they need to know where to look first. Quillfeather Labs reads each hospital's equipment maintenance logs and flags the infusion pumps and ventilators most likely to fail in the next 30 days. Key figures - $12 million Series A, led by Harrow Point Ventures, with Mill Race Capital and existing seed investor Tessellate Fund taking part - $15.5 million raised in total to date - 41 U.S. hospitals use Quillfeather Labs today, up from nine a year ago - 31% fewer surprise equipment failures at the nine hospitals that have used Quillfeather Labs for a full year, compared with the year before (Quillfeather Labs analysis of the hospitals' service records, 2025) "Biomed techs are the most overworked people in the hospital, and nobody knows they exist," said Priya Raman, co-founder and CEO of Quillfeather Labs. "Our whole job is to tell them which three machines to look at today. Scanners are the obvious next step because that's where the money and the waiting rooms are." [DRAFT QUOTE: approve with Priya Raman] Quillfeather Labs will use the round to double its engineering team, from 14 people today to about 30 by the end of 2027, and to open a second lab. The round also pays for the company's move into imaging equipment. Quillfeather Labs started with infusion pumps in 2022, added ventilators in 2025 and plans to start on CT and MRI scanners in 2027. Daniel Okafor, a partner at Harrow Point Ventures, joins the Quillfeather Labs board. "We looked at a dozen predictive maintenance companies," said Okafor. "Quillfeather was the only one whose customers renewed without being asked. Every one of them." [DRAFT QUOTE: approve with Daniel Okafor] The Quillfeather Labs platform overview is at quillfeather.example/platform. Raman's background is on the Quillfeather Labs team page at quillfeather.example/team. Frequently asked questions How much has Quillfeather Labs raised? Quillfeather Labs raised $12 million in a Series A round, for a total of $15.5 million raised to date. Who invested in the Quillfeather Labs Series A? Harrow Point Ventures led the round, with Mill Race Capital and existing seed investor Tessellate Fund taking part. Daniel Okafor of Harrow Point Ventures joins the Quillfeather Labs board. What does Quillfeather Labs do? Quillfeather Labs builds software that reads a hospital's equipment maintenance logs and predicts which infusion pumps and ventilators will fail in the next 30 days. Biomedical engineering teams use it to fix devices before they reach a patient. How many hospitals use Quillfeather Labs? Today, 41 U.S. hospitals use Quillfeather Labs, up from nine a year ago. Will Quillfeather Labs predict failures in CT and MRI scanners? Yes. The Series A pays for the move into imaging equipment, starting with CT and MRI scanners in 2027. About Quillfeather Labs Quillfeather Labs builds predictive maintenance software for hospital biomedical engineering teams. Its platform reads equipment service records and flags devices likely to fail, so teams can fix them before they reach a patient. Founded in 2022, Quillfeather is based in Pittsburgh. Learn more at quillfeather.example. Media contact Morgan Lee press@quillfeather.example +1 412-555-0142 ### ``` **Before you send** - **Quotes to approve:** - Priya Raman, co-founder and CEO, Quillfeather Labs. - Daniel Okafor, partner, Harrow Point Ventures. Get his approval from him directly, in writing. - **Facts and numbers to check:** - Okafor's quote claims every Quillfeather Labs customer renewed without being asked. Confirm this is true for all 41 hospitals, including those that have not reached a renewal date. - The 31% figure: it compares each of the nine hospitals' first full year with the year before, from the Quillfeather Labs analysis of 2025 service records. Confirm that window and source wording. - "Double the engineering team": 14 people today to about 30 by the end of 2027. - $15.5 million total raised to date, including the $12 million Series A. - 41 U.S. hospitals today, up from nine a year ago. - Timeline: infusion pumps in 2022, ventilators in 2025, CT and MRI scanners starting in 2027. - Okafor's board seat, which the release states as a fact. - Restated in the lede and the FAQ: the money grows the engineering team and pays for the move into scanners. - **Organizations to confirm can be named:** Harrow Point Ventures, Mill Race Capital, Tessellate Fund. - **Placeholders:** none. The release is ready to send when this list is done.